Journal
NEUROPATHOLOGY
Volume 25, Issue 4, Pages 304-314Publisher
WILEY
DOI: 10.1111/j.1440-1789.2005.00644.x
Keywords
alpha-synuclein; beta-amyloid; gliosis; inclusion; neurologically unimpaired
Categories
Ask authors/readers for more resources
The intracytoplasmic aggregation of alpha-synuclein (alpha S) protein is a common denominator for a group of neurodegenerative disorders currently known as synucleinopathies. It is generally assumed that the incorporation of alpha S protein into compact inclusions compromises the function and viability of its host cell via mechanical disruption. Herein, we report a widespread and abundant alpha S pathology in an elderly subject, whose medical history gave no indication of any neurodegenerative disease. We compared neuronal and glial components in this neurologically unimpaired subject with a patient with a clinical syndrome of dementia with Lewy bodies (DLB) by using a range of antigenic determinants and an in situ end-labeling technique. We detected no differences in vascular pathologies, in gliosis, or in apoptosis that would have explained the incompatible clinical end-points. With respect to the Alzheimer's disease-related changes, the only differences noted were the beta-amyloid aggregates in the putamen found in the DLB patient alone. Our findings suggest that there must be some currently unidentified factors rather than alpha S-positive inclusions that are responsible for the neuronal dysfunction. The alpha S-positive inclusions may well represent detoxified reserves that cells can tolerate for years, and thus prevention of their development could actually accelerate the diseases process.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available